Full Text
Indirect Comparison Of Pembrolizumab To Vemurafenib And Dabrafenib Monotherapy For First-Line Treatment Of Advanced Melanoma In Braf Mutation Positive Ipilimumab Naïve Patients

Abstract

Authors

JP Jansen K Stevinson J Wang

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×